Contact Us


Stories from cancer:

Prostate cancer is much easier to cure in its early stages, but can remain undiagnosed because early stages of the disease may not produce symptoms until the tumor is either very large or has invaded other tissues.

BYU biologist Jon Alder is currently studying the gene mutations that cause people to have unnaturally short telomeres, mutations that are connected to both pulmonary fibrosis and emphysema.

A BYU study in Nature Immunology could have significant impact on the development of vaccines. This research joins other studies taking place at BYU, helping improve treatment and diagnosis in the fields of cancer, Alzheimer’s and other diseases.

One of the hopes for victory against cancer hinges on naturally-occurring proteins whose job is to make their host cell die.

BYU neuroscience major Jesse Cobell graduates this month with an impressive line on his resume: Co-authored research in the world’s most highly-cited scientific journal.

Researchers at the University of Iowa and Brigham Young University have pinpointed a gene that causes cancer patients to develop resistance to drug therapy. The discovery is a first step in creating new, effective therapeutic treatments for sufferers of aggressive cancers such as multiple myeloma that respond poorly to treatment.

Sharla Morgan had never suspected anything wrong with her health – no pain or other symptoms. But the graduate student in the College of Nursing at Brigham Young University happened to be in the right place at the right time for her professor to spot a well-concealed threat.

Researchers at BYU have created a micro device that could both decrease the amount of blood and time needed to test for cancer-markers in a patient’s blood.